BioAge Labs

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAge Labs and other ETFs, options, and stocks.

About BIOA

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. 

CEO
Kristen Fortney
CEOKristen Fortney
Employees
64
Employees64
Headquarters
Richmond, California
HeadquartersRichmond, California
Founded
2015
Founded2015
Employees
64
Employees64

BIOA Key Statistics

Market cap
147.16M
Market cap147.16M
Price-Earnings ratio
-1.96
Price-Earnings ratio-1.96
Dividend yield
Dividend yield
Average volume
281.82K
Average volume281.82K
High today
$4.24
High today$4.24
Low today
$3.93
Low today$3.93
Open price
$4.06
Open price$4.06
Volume
422.58K
Volume422.58K
52 Week high
$26.62
52 Week high$26.62
52 Week low
$2.88
52 Week low$2.88

People also own

Based on the portfolios of people who own BIOA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.